HRP950524B1 - Quinoxaline, process for its preparation and the use thereof - Google Patents

Quinoxaline, process for its preparation and the use thereof

Info

Publication number: HRP950524B1
Authority: HR; Croatia
Prior art keywords: quinoxaline; alkoxy; preparation; formula; carbonyl
Prior art date: 1994-10-19

Application number

HR950524A

Other languages

English (en)

Inventor

Manfred Roesner

Uta-Maria Billhardt-Troughton

Reinhard Kirsch

Joerg-Peter Kleim

Cristoph Meichsner

Guenther Riess

Irvin Winkler

Original Assignee

Aventis Pharma Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-19

Filing date

1995-10-18

Publication date

2002-06-30

1995-10-18 Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh

1997-10-31 Publication of HRP950524A2 publication Critical patent/HRP950524A2/hr

2002-06-30 Publication of HRP950524B1 publication Critical patent/HRP950524B1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Virology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Dental Preparations (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Compounds Of Unknown Constitution (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Medicinal Preparation (AREA)
Plural Heterocyclic Compounds (AREA)

HR950524A 1994-10-19 1995-10-18 Quinoxaline, process for its preparation and the use thereof HRP950524B1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE4437406A DE4437406A1 (de)	1994-10-19	1994-10-19	Chinoxaline, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (2)

Publication Number	Publication Date
HRP950524A2 HRP950524A2 (en)	1997-10-31
HRP950524B1 true HRP950524B1 (en)	2002-06-30

Family

ID=6531202

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR950524A HRP950524B1 (en)	1994-10-19	1995-10-18	Quinoxaline, process for its preparation and the use thereof

Country Status (28)

Country	Link
US (1)	US5723461A (pt)
EP (1)	EP0708093B1 (pt)
JP (1)	JPH08225544A (pt)
KR (1)	KR960014108A (pt)
CN (1)	CN1094930C (pt)
AT (1)	ATE198747T1 (pt)
AU (1)	AU708293B2 (pt)
BR (1)	BR9504456A (pt)
CA (1)	CA2160859A1 (pt)
CZ (1)	CZ271295A3 (pt)
DE (2)	DE4437406A1 (pt)
DK (1)	DK0708093T3 (pt)
ES (1)	ES2154311T3 (pt)
FI (1)	FI954946L (pt)
GR (1)	GR3035673T3 (pt)
HK (1)	HK1011988A1 (pt)
HR (1)	HRP950524B1 (pt)
HU (1)	HUT73485A (pt)
IL (1)	IL115641A0 (pt)
MY (1)	MY132057A (pt)
NO (1)	NO306615B1 (pt)
NZ (1)	NZ280258A (pt)
PL (1)	PL184860B1 (pt)
PT (1)	PT708093E (pt)
SI (1)	SI9500329A (pt)
SK (1)	SK128495A3 (pt)
TW (1)	TW328954B (pt)
ZA (1)	ZA958783B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6369057B1 (en) *	1991-04-15	2002-04-09	Aventis Pharma Deutschland Gmbh	Quinoxalines, processes for their preparation and their use
US6015800A (en) *	1997-09-03	2000-01-18	Warner-Lambert Company	Substituted quinoxaline-2-ones as glutamate receptor antagonists
AU9318298A (en) *	1997-11-14	1999-06-07	Warner-Lambert Company	Small molecule intervention in hiv-1 replication
GB9901795D0 (en) *	1999-01-28	1999-03-17	Glaxo Group Ltd	Chemical compounds
GB9911887D0 (en) *	1999-05-21	1999-07-21	Glaxo Group Ltd	Methods and medicaments for post exposure prophylaxis of an hiv infection
US20030114385A1 (en) *	2001-04-27	2003-06-19	Cathers Brian E.	Viral enzyme activated prototoxophores and use of same to treat viral infections
WO2005018531A2 (fr) *	2003-08-26	2005-03-03	'chemical Diversity Research Institute', Ltd.	Compositions pharmaceutiques, composes azo-heterocycliques et procedes de fabrication et d'utilisation correspondants
US7351709B2 (en) *	2004-06-09	2008-04-01	Wyeth	Estrogen receptor ligands
NZ731797A (en)	2012-04-24	2018-08-31	Vertex Pharma	Dna-pk inhibitors
RU2676259C2 (ru)	2013-03-12	2018-12-27	Вертекс Фармасьютикалз Инкорпорейтед	Ингибиторы днк-пк
PL3424920T3 (pl)	2013-10-17	2020-11-16	Vertex Pharmaceuticals Incorporated	Kokryształy (S)-N-metylo-8-(1-((2'-metylo-4’,6'-dideutero-[4,5'-bipirymidyn]-6-ylo)amino)propan-2-ylo)chinolino-4-karboksyamidu i ich deuterowane pochodne jako inhibitory DNA-PK
EP3518931A4 (en)	2016-09-27	2020-05-13	Vertex Pharmaceuticals Incorporated	Method for treating cancer using a combination of dna-damaging agents and dna-pk inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE205837T1 (de) *	1991-04-15	2001-10-15	Aventis Pharma Gmbh	Chinoxaline, verfahren zu ihrer herstellung und ihre verwendung
DE4342024A1 (de) *	1993-12-09	1995-06-14	Hoechst Ag	Kombinationspräparate, enthaltend ein Chinoxalin und ein Nukleosid

1994
- 1994-10-19 DE DE4437406A patent/DE4437406A1/de not_active Withdrawn
1995
- 1995-10-12 PT PT95116094T patent/PT708093E/pt unknown
- 1995-10-12 AT AT95116094T patent/ATE198747T1/de not_active IP Right Cessation
- 1995-10-12 EP EP95116094A patent/EP0708093B1/de not_active Expired - Lifetime
- 1995-10-12 DK DK95116094T patent/DK0708093T3/da active
- 1995-10-12 DE DE59508969T patent/DE59508969D1/de not_active Expired - Fee Related
- 1995-10-12 ES ES95116094T patent/ES2154311T3/es not_active Expired - Lifetime
- 1995-10-15 IL IL11564195A patent/IL115641A0/xx unknown
- 1995-10-16 TW TW084110841A patent/TW328954B/zh active
- 1995-10-17 NZ NZ280258A patent/NZ280258A/en unknown
- 1995-10-17 FI FI954946A patent/FI954946L/fi unknown
- 1995-10-17 US US08/544,290 patent/US5723461A/en not_active Expired - Fee Related
- 1995-10-17 AU AU34316/95A patent/AU708293B2/en not_active Ceased
- 1995-10-17 SK SK1284-95A patent/SK128495A3/sk unknown
- 1995-10-17 CZ CZ952712A patent/CZ271295A3/cs unknown
- 1995-10-17 MY MYPI95003112A patent/MY132057A/en unknown
- 1995-10-18 HU HU9503005A patent/HUT73485A/hu unknown
- 1995-10-18 KR KR1019950035876A patent/KR960014108A/ko not_active Abandoned
- 1995-10-18 CN CN95120372A patent/CN1094930C/zh not_active Expired - Fee Related
- 1995-10-18 CA CA002160859A patent/CA2160859A1/en not_active Abandoned
- 1995-10-18 HR HR950524A patent/HRP950524B1/xx not_active IP Right Cessation
- 1995-10-18 PL PL95311016A patent/PL184860B1/pl unknown
- 1995-10-18 ZA ZA958783A patent/ZA958783B/xx unknown
- 1995-10-18 NO NO954139A patent/NO306615B1/no not_active IP Right Cessation
- 1995-10-19 JP JP7271019A patent/JPH08225544A/ja active Pending
- 1995-10-19 SI SI9500329A patent/SI9500329A/sl unknown
- 1995-10-19 BR BR9504456A patent/BR9504456A/pt not_active IP Right Cessation
1998
- 1998-12-12 HK HK98113241A patent/HK1011988A1/xx not_active IP Right Cessation
2001
- 2001-03-30 GR GR20010400523T patent/GR3035673T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
MY132057A (en)	2007-09-28
CN1135483A (zh)	1996-11-13
KR960014108A (ko)	1996-05-22
DE4437406A1 (de)	1996-04-25
US5723461A (en)	1998-03-03
CZ271295A3 (en)	1996-08-14
NO954139L (no)	1996-04-22
SK128495A3 (en)	1996-06-05
NZ280258A (en)	1997-09-22
ES2154311T3 (es)	2001-04-01
DE59508969D1 (de)	2001-02-22
IL115641A0 (en)	1996-01-19
HRP950524A2 (en)	1997-10-31
PL311016A1 (en)	1996-04-29
EP0708093A1 (de)	1996-04-24
CN1094930C (zh)	2002-11-27
HK1011988A1 (en)	1999-07-23
EP0708093B1 (de)	2001-01-17
JPH08225544A (ja)	1996-09-03
SI9500329A (en)	1996-04-30
AU3431695A (en)	1996-05-02
FI954946L (fi)	1996-04-20
AU708293B2 (en)	1999-07-29
CA2160859A1 (en)	1996-04-20
PT708093E (pt)	2001-06-29
DK0708093T3 (da)	2001-04-30
HUT73485A (en)	1996-08-28
ATE198747T1 (de)	2001-02-15
TW328954B (en)	1998-04-01
PL184860B1 (pl)	2003-01-31
ZA958783B (en)	1996-05-09
BR9504456A (pt)	1997-05-20
NO954139D0 (no)	1995-10-18
NO306615B1 (no)	1999-11-29
GR3035673T3 (en)	2001-06-29
FI954946A0 (fi)	1995-10-17
HU9503005D0 (en)	1995-12-28

Publication	Publication Date	Title
HU9302696D0 (en)	1993-12-28	Process for producing aza quinoxaline derivatives and medical preparatives containing these compounds
HK125296A (en)	1996-07-19	Quinolone-carboxylic acid derivative
HRP950524B1 (en)	2002-06-30	Quinoxaline, process for its preparation and the use thereof
EP0342675A3 (en)	1990-12-27	Novel quinolonecarboxylic acid derivatives
NZ290389A (en)	1999-03-29	Substituted pyrimidines typically substituted by -piperazin-1-yl
HK1011971A1 (en)	1999-07-23	Quinoxalines, process for their preparation and their use
DE3682032D1 (de)	1991-11-21	Propylamine, verfahren zu ihrer herstellung und ihre verwendung als fungizide.
IL118368A (en)	1997-09-30	N-oxide quinoxaline derivatives
IL117150A (en)	2001-03-19	Substituted benzenesulfonylureas and - thioureas processes for their preparation their use in the preparation of medicaments and pharmaceutical compositions containing them
ES2145561T3 (es)	2000-07-01	Derivados bencilo(s) sustituido(s) de polialquilenpoliamidas y su utilizacion en composiciones cosmeticas y farmaceuticas.
AU1639197A (en)	1997-09-25	Pyridine derivative, anti-ulcer drug, and antibacterial drug
EP0487996B1 (de)	1998-07-22	3-substituierte Cephalosporine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
MX9705379A (es)	1997-10-31	Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis vasodilatadora.
ES8202811A1 (es)	1982-03-01	Un procedimiento para la preparacion de derivados de benzo (1,4) dioxina
MX9705390A (es)	1997-10-31	Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales.
IL99369A0 (en)	1992-08-18	Pharmaceutical compositions containing substituted 2-cyclohexene derivatives
ZA908309B (en)	1991-08-28	Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives
ES459473A1 (es)	1978-04-16	Procedimiento para la preparacion de nuevas 9-alcohilamino- eritromicinas.

Legal Events

Date	Code	Title	Description
1997-10-31	A1OB	Publication of a patent application
1998-04-30	AIPI	Request for the grant of a patent on the basis of a substantive examination of a patent application
2001-03-21	PPPP	Transfer of rights	Owner name: AVENTIS PHARMA DEUTSCHLAND GMBH, DE
2002-06-30	B1PR	Patent granted
2002-10-18	ODRP	Renewal fee for the maintenance of a patent	Payment date: 20021018 Year of fee payment: 8
2004-04-19	PBON	Lapse due to non-payment of renewal fee	Effective date: 20031019